DCIS_BREAST_EXCIS

Description:

Stores data for College of American Pathologists (CAP) form 76013-DCIS OF THE BREAST: Complete Excision (Less Than Total Mastectomy, Including Specimens Designated Biopsy, Lumpectomy, Quadrantectomy, and Partial Mastectomy; With or Without Axillary Contents) and Mastectomy (Total, Modified Radical, Radical; With or Without Axillary Contents).

Primary Key

Column Name	Ordinal Position
RESULT_ID	1

Column Information

	Name	Type	Discontinued?
1	RESULT_ID	VARCHAR	No
	The unique identifier for the result record.
2	TUMOR_SITE_SPECIFY	VARCHAR	No
	CAP synoptic form item: Specify tumor site.
3	CLOCK_POSITION_C_NAME	VARCHAR	No
	CAP synoptic form item: Specify Clock Position of Tumor Site. May contain organization-specific values: Yes Category Entries: 1 o'clock 2 o'clock 3 o'clock 4 o'clock 5 o'clock 6 o'clock 7 o'clock 8 o'clock 9 o'clock 10 o'clock 11 o'clock 12 o'clock Other
4	CAP_COMMENTS	VARCHAR	No
	CAP synoptic form item: General comments.
5	SPEC_INTEGRITY_C_NAME	VARCHAR	No
	CAP synoptic form item: Specimen Integrity. May contain organization-specific values: Yes Category Entries: Intact Fragmented Single intact specimen (margins can be evaluated) Multiple designated specimens (e.g., main excision and identified margins) Fragmented (margins cannot be evaluated with certainty) Morcellated hysterectomy specimen Intact hysterectomy specimen Disrupted Indeterminate Other Not specified
6	SPEC_INTEGRITY_SPFY	VARCHAR	No
	CAP synoptic form item: Specify specimen integrity.
7	SPEC_PROC_SPECIFY	VARCHAR	No
	CAP synoptic form item: Specify the Specimen Procedure.
8	SPEC_SIZE_GREATEST	NUMERIC	No
	CAP synoptic form item: Specimen Greatest Size.
9	SPEC_SIZE_ADDL	NUMERIC	No
	CAP synoptic form item: Specimen size additional dimension (length).
10	SPEC_SIZE_ADDL2	NUMERIC	No
	CAP synoptic form item: Specimen size additional dimension (width).
11	TREATMENT_EFFECT_C_NAME	VARCHAR	No
	CAP synoptic form item: Treatment Effect. May contain organization-specific values: Yes Category Entries: Not identified No prior treatment Not applicable Present No definite response identified (grade 3, poor/no response; extensive residual tumor) No definite response identified (grade 3, poor or no response) Greater than 10% residual viable tumor Less than 10% residual viable tumor Greater than 50% residual viable tumor Less than 50% residual viable tumor No definite or minimal response identified (poor or no response) Marked response (minimal residual cancer) No known presurgical therapy No definite response to presurgical therapy Probable or definite response to presurgical therapy Cannot be determined Indeterminate Not known
12	MARGIN_DCIS_C_NAME	VARCHAR	No
	CAP synoptic form item: Margin DCIS. May contain organization-specific values: Yes Category Entries: Margins cannot be assessed DCIS not present in specimen Margins uninvolved by DCIS (DCIS present) Margin(s) positive for DCIS
13	RADIOLOG_FIND_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Radiologic Findings.
14	CLINICAL_HIST_SPFY	VARCHAR	No
	CAP synoptic form item: Specify clinical history.
15	HST_BRST_CANCR_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Prior History of Breast Cancer.
16	LYMPH_ND_SAMPL_SPFY	VARCHAR	No
	CAP synoptic form item: Specify lymph node sampling.
17	SPECIMEN_OTHER_SPFY	VARCHAR	No
	CAP synoptic form item: Specify other specimen.
18	SIZE_DCIS_GREAT_DIM	NUMERIC	No
	CAP synoptic form item: Estimated Size of DCIS Greatest Dimension.
19	DCIS_ADDL_DIMENSION	NUMERIC	No
	CAP synoptic form item: DCIS Additional Dimension Length.
20	DCIS_ADDL_DIM_2	NUMERIC	No
	CAP synoptic form item: DCIS Additional Dimension Width.
21	NUM_BLOCK_EXAM_DCIS	NUMERIC	No
	CAP synoptic form item: Number of Blocks Examined for DCIS.
22	NUM_BLOCKS_DCIS	NUMERIC	No
	CAP synoptic form item: Number of Blocks With DCIS.
23	ARCHITECT_PAT_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Architectural Patterns.
24	NECROSIS_C_NAME	VARCHAR	No
	CAP synoptic form item: Necrosis. May contain organization-specific values: Yes Category Entries: Not identified Present Present, focal (small foci or single cell necrosis) Present, central (expansive "comedo" necrosis) Not applicable Cannot be determined
25	NUCLEAR_GRADE_C_NAME	VARCHAR	No
	CAP synoptic form item: Nuclear Grade. May contain organization-specific values: Yes Category Entries: Grade I (low) Grade II (intermediate) Grade III (high)
26	DCIS_CLOSEST_MARGIN	NUMERIC	No
	CAP synoptic form item: DCIS Distance from Closest Margin.
27	DCIS_SUPERIOR_MRG	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Superior Margin.
28	DCIS_INFERIOR_MRG	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Inferior Margin.
29	DCIS_ANTERIOR_MRG	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Anterior Margin.
30	DCIS_POSTERIOR_MRG	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Posterior margin.
31	DCIS_MEDIAL_MARGIN	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Medial Margin.
32	DCIS_LATERAL_MARGIN	NUMERIC	No
	CAP synoptic form item: DCIS Distance to Lateral Margin.
33	DCIS_OTHER_MARGIN	NUMERIC	No
	CAP synoptic form item: DCIS Distance from Other Specified margin.
34	DCIS_DESIGNAT_MRG	VARCHAR	No
	CAP synoptic form item: DCIS Designation of Margin.
35	DCIS_SUPERIOR_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Superior Margin Extent. May contain organization-specific values: Yes Category Entries: Focal Minimal / moderate Extensive
36	DCIS_INFERIOR_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Inferior Margin Extent. The category values for this column were already listed for column: DCIS_SUPERIOR_EXT_C_NAME
37	DCIS_ANTERIOR_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Anterior Margin Extent. The category values for this column were already listed for column: DCIS_SUPERIOR_EXT_C_NAME
38	DCIS_POSTERR_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Posterior Margin Extent. The category values for this column were already listed for column: DCIS_SUPERIOR_EXT_C_NAME
39	DCIS_MEDIAL_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Medial Margin Extent. The category values for this column were already listed for column: DCIS_SUPERIOR_EXT_C_NAME
40	DCIS_LATER_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: DCIS Lateral Margin Extent. The category values for this column were already listed for column: DCIS_SUPERIOR_EXT_C_NAME
41	LYM_ND_NOT_PRES_YN	VARCHAR	No
	CAP synoptic form item: Lymph Nodes Present in Specimen. May contain organization-specific values: No Category Entries: No Yes
42	TOT_NUM_LYM_ND_EXAM	NUMERIC	No
	CAP synoptic form item: Total Number of Lymph Nodes Examined (Sentinel and Nonsentinel).
43	NUM_LYM_ND_ISO_TMR	NUMERIC	No
	CAP synoptic form item: Number of Lymph Nodes with Isolated Tumor Cells.
44	MIC_MC_METAS_PRE_YN	VARCHAR	No
	CAP synoptic form item: Micro/Macro Metastases Present. The category values for this column were already listed for column: LYM_ND_NOT_PRES_YN
45	NUM_LYM_ND_MACROMET	NUMERIC	No
	CAP synoptic form item: Number of Lymph Nodes with Macrometastases.
46	NUM_LYM_ND_MICROMET	NUMERIC	No
	CAP synoptic form item: Number of Lymph Nodes with Micrometastases.
47	SZ_LRGST_METAS_DEP	NUMERIC	No
	CAP synoptic form item: Size of Largest Metastatic Deposit.
48	LYMPH_NODES_UNITS_C_NAME	VARCHAR	No
	CAP synoptic form item: Lymph Nodes - Specify Units. May contain organization-specific values: Yes Category Entries: mm cm
49	SENT_BIOP_NT_PER_YN	VARCHAR	No
	CAP synoptic form item: Sentinel Lymph Node - Biopsy Not Performed. The category values for this column were already listed for column: LYM_ND_NOT_PRES_YN
50	NUM_SENT_LYM_EXAM	NUMERIC	No
	CAP synoptic form item: Number of Sentinel Lymph Nodes Examined.
51	EVAL_SENT_ND_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Method of Evaluation of Sentinel Lymph Nodes.
52	LYM_ND_EXNDL_EXT_C_NAME	VARCHAR	No
	CAP synoptic form item: Lymph Nodes, Extranodal Extension. May contain organization-specific values: Yes Category Entries: Cannot be assessed Not identified Absent Present Indeterminate Portal vein invasion present Hepatic vein invasion present Present within tumor nodules Present in vessels of parenchyma outside of tumor nodules Cannot be determined
53	ESTRGN_RECEPTOR_C_NAME	VARCHAR	No
	CAP synoptic form item: Estrogen Receptor. May contain organization-specific values: Yes Category Entries: Performed Immunoreactive tumor cells present No immunoreactive tumor cells present Pending Not performed Other
54	ESTROGEN_RECP_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Estrogen Receptor.
55	ESTRGN_ANTBOD_VEND	VARCHAR	No
	CAP synoptic form item: Estrogen Receptor - Antibody Vendor and Clone.
56	ESTRGN_TYPE_FIXTVE	VARCHAR	No
	CAP synoptic form item: Estrogen Receptor - Type of Fixative.
57	PROGESTERONE_RECP_C_NAME	VARCHAR	No
	CAP synoptic form item: Progesterone Receptor. The category values for this column were already listed for column: ESTRGN_RECEPTOR_C_NAME
58	PRGSTRN_RECP_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Progesterone Receptor.
59	PRGSTN_ANTBOD_VEND	VARCHAR	No
	CAP synoptic form item: Progesterone Receptor - Antibody Vendor.
60	PRGSTN_TYPE_FIXTIVE	VARCHAR	No
	CAP synoptic form item: Progesterone Receptor - Type of Fixative.
61	PRIMARY_TUMOR_C_NAME	VARCHAR	No
	CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified
62	LYMPH_ND_MODIFIE_YN	VARCHAR	No
	CAP synoptic form item: Lymph Node Modifier. The category values for this column were already listed for column: LYM_ND_NOT_PRES_YN
63	LYMPH_ND_CAT_C_NAME	VARCHAR	No
	CAP synoptic form item: Lymph Node Category. May contain organization-specific values: Yes Category Entries: pNX: Regional lymph nodes cannot be assessed pN0: No regional lymph node metastasis identified histologically pN0 (i-): No regional lymph node metastases histologically, negative IHC pN0 (i+): Malig. cells in reg. lym node no greater than 0.2mm, no more than 200 cells pN0 (mol-): No regional lymph node metastases histologically, negative molecular find pN0 (mol+): Positive molecular findings, but no regional lymph node metastases pN1mi: Micrometastases (greater than 0.2mm and/or more than 200 cells, none > 2.0mm) pN1a: Metastases in 1-3 axillary lym. nodes, at least 1 metastasis greater than 2.0mm pN2a: Metastases in 4-9 axillary lymph nodes (at least 1 tumor deposit > 2.0mm) pN3a: Metastases in 10+ axillary lymph nodes (at least 1 tumor deposit > 2.0mm) Other
64	LYM_ND_CAT_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Lymph Node Category.
65	DISTNT_METASTASIS_C_NAME	VARCHAR	No
	CAP synoptic form item: Distant Metastasis. May contain organization-specific values: Yes Category Entries: Not applicable cM0 (i+): No clinical or radiographic evidence of distant metastasis pM0: No distant metastasis pM1: Distant metastasis pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx pM1b: Nonperitoneal metastasis pM1: Distant detectable metastasis as determined by classic clinical pM1 (IVB): Distant metastasis pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or pM1b: Distant metastases outside the lung / pleura pM1: Distant metastasis (documented in this specimen) pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1b: Metastasis to lung pM1c: Metastasis to all other visceral sites or distant metastasis at any site pM1a: Nonregional lymph node(s) pM1b: Bone(s) pM1c: Other site(s) with or without bone disease pM1: Metastasis to sites other than CNS pM1a: Single lesion pM1b: Multiple lesions pM1c: CNS metastasis pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement pM1e: Leptomeningeal and / or CSF involvement pM1a: Non-regional lymph nodes or pulmonary metastasis pM1b: Distant metastasis other than to nonregional lymph nodes and lungs pM1a (III): Tumor extends to the lungs with or without genital tract involvement pM1b (IV): Tumor involves other metastatic sites pM1a: Largest diameter of the largest metastasis 3 cm or less pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm pM1c: Largest diameter of the largest metastasis 8 cm or more pM1a: Lung pM1b: Metastasis involving distant sites other than lung (including skip metastases) Distant Metastasis present (includes metastasis to lymph nodes)
66	ADDL_PATH_FIND_SPFY	VARCHAR	No
	CAP synoptic form item: Specify additional pathologic findings.
67	PR_TREAT_DCIS_SPFY	VARCHAR	No
	CAP synoptic form item: Specify Prior Neoadjuvant Treatment for this Diagnosis of DCIS.
68	ESTROGEN_ANTIBODY	VARCHAR	No
	CAP synoptic form item: Estrogen Receptor - Antibody.
69	PROGESTER_ANTIBODY	VARCHAR	No
	CAP synoptic form item: Progesterone Receptor - Antibody.